Jorgen Vestbo, MD, discusses new COPERNICOS trial data showing patients who do not meet a specific eosinophil threshold can have inhaled ICS safely reduced.
Jorgen Vestbo, MD
Advertisement
Jørgen Vestbo is a professor of respiratory medicine and an honorary consultant at the North West Lung Centre, Manchester University Hospital NHS Foundation Trust.
Articles by Jorgen Vestbo, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
COPD Deaths Rival Heart Failure, Exceed Prostate and Breast Cancer
2
AI Model Flags Colorectal Cancer on Routine Noncontrast CT Scans
3
FDA Approves Camizestrant for ER+, HER2– mBC With ESR1 Mutations
4
Vutrisiran Effects Consistent With, Without Tafamidis in ATTR-CM
5